DHA attenuates postprandial hyperlipidemia via activating PPARα in intestinal epithelial cells

Journal of Lipid Research

Volumn 54, Issue 12, 2013, Pages 3258-3268

  Kimura, Rino ^a   Takahashi, Nobuyuki ^a,b   Lin, Shan ^a   Goto, Tsuyoshi ^a,b   Murota, Kaeko ^c   Nakata, Rieko ^d   Inoue, Hiroyasu ^d   Kawada, Teruo ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cardiovascular diseases; Docosahexaenoic acid; Dyslipidemia; Fatty acid oxidation; Peroxisome proliferator activated receptor ; Polyunsaturated fatty acid; Small intestine; Triacylglyceride

Indexed keywords

APOLIPOPROTEIN B; DOCOSAHEXAENOIC ACID; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL;

36B4 GENE; ACS GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AOX GENE; ARTICLE; CD36 GENE; CELL STRAIN CACO 2; CONTROLLED STUDY; CPT1A GENE; EPITHELIUM CELL; FABP GENE; FATTY ACID OXIDATION; GENE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; KNOCKOUT MOUSE; LIVER; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UCP2 GENE;

CARDIOVASCULAR DISEASES; DOCOSAHEXAENOIC ACID; DYSLIPIDEMIA; FATTY ACID OXIDATION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Α; POLYUNSATURATED FATTY ACID; SMALL INTESTINE; TRIACYLGLYCERIDE;

ANIMALS; APOLIPOPROTEINS B; CACO-2 CELLS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS; HUMANS; HYPERLIPIDEMIAS; INTESTINAL MUCOSA; MICE; OXIDATION-REDUCTION; OXYGEN; POSTPRANDIAL PERIOD; PPAR ALPHA; TRIGLYCERIDES;

EID: 84887883548     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M034942     Document Type: Article

References (47)

1. Ogden, C. L., S. Z. Yanovski, M. D. Carroll, and K. M. Flegal. 2007. The epidemiology of obesity. Gastroenterology. 132:2087-2102. (Pubitemid 46693751)
2. Bansal, S., J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M. Ridker. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 298:309-316. (Pubitemid 47080485)
3. Freiberg, J. J., A. Tybjaerg-Hansen, J. S. Jensen, and B. G. Nordestgaard. 2008. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA. 300:2142-2152.
4. Iso, H., Y. Naito, S. Sato, A. Kitamura, T. Okamura, T. Sankai, T. Shimamoto, M. Iida, and Y. Komachi. 2001. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am. J. Epidemiol. 153:490-499. (Pubitemid 32185086)
5. Boquist, S., G. Ruotolo, R. Tang, J. Björkegren, M. G. Bond, U. De Faire, F. Karpe, and A. Hamsten. 1999. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation. 100:723-728. (Pubitemid 29383642)
6. Patsch, J. R., G. Miesenböck, T. Hopferwieser, V. Mühlberger, E. Knapp, J. K. Dunn, A. M. Gotto, Jr., and W. Patsch. 1992. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12:1336-1345.
7. Björkegren, J., S. Boquist, A. Samnegârd, P. Lundman, P. Tornvall, C. G. Ericsson, and A. Hamsten. 2000. Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease. Circulation. 101:227-230. (Pubitemid 30054146)
8. Bünger, M., H. M. Van Den Bosch, J. Van Der Meijde, S. Kersten, G. Hooiveld, and M. Müller. 2007. Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol. Genomics. 30:192-204. (Pubitemid 47173282)
9. Kersten, S., B. Desvergne, and W. Wahli. 2000. Roles of PPARs in health and disease. Nature. 405:421-424. (Pubitemid 30367411)
10. Hashimoto, T., W. Cook, C. Qi, A. Yeldandi, J. Reddy, and M. Rao. 2000. Defect in peroxisome proliferator-activated receptor alpha inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275:28918-28928.
11. Minnich, A., N. Tian, L. Byan, and G. Bilder. 2001. A potent PPAR agonist stimulates mitochondrial fatty acid-oxidation in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 280:E270 - E279.
12. Schoonjans, K., B. Staels, and J. Auwerx. 1996. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:907-925. (Pubitemid 26182326)
13. Akiyama, T. E., C. J. Nicol, C. Fievet, B. Staels, J. M. Ward, J. Auwerx, S. S. Lee, F. J. Gonzalez, and J. M. Peters. 2001. Peroxisome proliferatoractivated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J. Biol. Chem. 276:39088-39093.
14. Lindén, D., M. Alsterholm, H. Wennbo, and J. Oscarsson. 2001. PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins. J. Lipid Res. 42:1831-1840. (Pubitemid 33116714)
15. Kimura, R., N. Takahashi, K. Murota, Y. Yamada, S. Niiya, N. Kanzaki, Y. Murakami, T. Moriyama, T. Goto, and T. Kawada. 2011. Activation of peroxisome proliferator-activated receptor-β (PPAR β) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes. Biochem. Biophys. Res. Commun. 410:1-6.
16. Uchida, A., M. N. Slipchenko, J. X. Cheng, and K. K. Buhman. 2011. Fenofibrate, a peroxisome proliferator-activated receptor β agonist, alters triglyceride metabolism in enterocytes of mice. Biochim. Biophys. Acta. 1811:170-176.
17. Wong, S. H., E. A. Fisher, and J. B. Marsh. 1989. Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low density lipoprotein in HepG2 cells. Arteriosclerosis. 9:836-841. (Pubitemid 20002215)
18. Nestel, P. J., W. E. Connor, M. F. Reardon, S. Connor, S. Wong, and R. Boston. 1984. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J. Clin. Invest. 74:82-89. (Pubitemid 14086047)
19. Park, Y., and W. S. Harris. 2003. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J. Lipid Res. 44:455-463. (Pubitemid 37279692)
20. Van Schothorst, E. M., P. Flachs, N. L. Franssen-Van Hal, O. Kuda, A. Bunschoten, J. Molthoff, C. Vink, G. J. Hooiveld, J. Kopecky, and J. Keijer. 2009. Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. BMC Genomics. 10:110.
21. Goto, T., N. Takahashi, S. Kato, K. Egawa, S. Ebisu, T. Moriyama, T. Fushiki, and T. Kawada. 2005. Phytol directly activates peroxisome proliferator-activated receptor alpha (PPAR alpha) and regulates gene expression involved in lipid metabolism in PPAR alphaexpressing HepG2 hepatocytes. Biochem. Biophys. Res. Commun. 337:440-445. (Pubitemid 41429304)
22. Kuroyanagi, K., M. S. Kang, T. Goto, S. Hirai, K. Ohyama, T. Kusudo, R. Yu, M. Yano, T. Sasaki, N. Takahashi, et al. 2008. Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 366:219-225. (Pubitemid 50007730)
23. Takahashi, N., M. Senda, S. Lin, T. Goto, M. Yano, T. Sasaki, S. Murakami, and T. Kawada. 2011. Auraptene regulates gene expression involved in lipid metabolism through PPARα activation in diabetic obese mice. Mol. Nutr. Food Res. 55:1791-1797.
24. Wu, M., A. Neilson, A. L. Swift, R. Moran, J. Tamagnine, D. Parslow, S. Armistead, K. Lemire, J. Orrell, J. Teich, et al. 2007. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol. 292:C125 - C136. (Pubitemid 46115126)
25. Goto, T., J. Y. Lee, A. Teraminami, Y. I. Kim, S. Hirai, T. Uemura, H. Inoue, N. Takahashi, and T. Kawada. 2011. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J. Lipid Res. 52:873-884.
26. Hernández Vallejo, S. J., M. Alqub, S. Luquet, C. Cruciani-Guglielmacci, P. Delerive, J. M. Lobaccaro, A. D. Kalopissis, J. Chambaz, M. Rousset, and J. M. Lacorte. 2009. Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G782 - G792.
27. Nakatani, T., H. J. Kim, Y. Kaburagi, K. Yasuda, and O. Ezaki. 2003. A low fish oil inhibits SREBP-1 proteolytic cascade, while a highfish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. J. Lipid Res. 44:369-379. (Pubitemid 37287780)
28. Lin, X., P. Yue, Z. Chen, and G. Schonfeld. 2005. Hepatic triglyceride contents are genetically determined in mice: results of a strain survey. Am. J. Physiol. Gastrointest. Liver Physiol. 288:G1179 - G1189. (Pubitemid 40741070)
29. Eder, K., A. M. Reichlmayr-Lais, and M. Kirchgessner. 1993. Studies on the extraction of phospholipids from erythrocyte membranes in the rat. Clin. Chim. Acta. 219:93-104. (Pubitemid 23332664)
30. Perera, M. A., S. Y. Choi, E. S. Wurtele, and B. J. Nikolau. 2009. Quantitative analysis of short-chain acyl-coenzyme As in plant tissues by LC-MS-MS electrospray ionization method. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877:482-488.
31. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
32. Fu, J., S. Gaetani, F. Oveisi, J. Lo Verme, A. Serrano, F. Rodríguez De Fonseca, A. Rosengarth, H. Luecke, B. Di Giacomo, G. Tarzia, et al. 2003. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 425:90-93. (Pubitemid 37101723)
33. Escher, P., O. Braissant, S. Basu-Modak, L. Michalik, W. Wahli, and B. Desvergne. 2001. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology. 142:4195-4202. (Pubitemid 32907045)
34. Kim, Y. I., S. Hirai, T. Goto, C. Ohyane, H. Takahashi, T. Tsugane, C. Konishi, T. Fujii, S. Inai, Y. Iijima, et al. 2012. Potent PPARα activator derived from tomato juice, 13-oxo-9, 11-octadecadienoic acid, decreases plasma and hepatic triglyceride in obese diabetic mice. PLoS ONE. 7:e31317.
35. Shen, P., M. H. Liu, T. Y. Ng, Y. H. Chan, and E. L. Yong. 2006. Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J. Nutr. 136:899-905.
36. De Vogel-Van Den Bosch, H. M., M. Bünger, P. J. De Groot, H. Bosch-Vermeulen, G. J. Hooiveld, and M. Müller. 2008. PPARalphamediated effects of dietary lipids on intestinal barrier gene expression. BMC Genomics. 9:231
37. Mori, T., H. Kondo, T. Hase, I. Tokimitsu, and T. Murase. 2007. Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. J. Nutr. 137:2629-2634. (Pubitemid 350255289)
38. Shearer, G. C., O. V. Savinova, and W. S. Harris. 2012. Fish oil - How does it reduce plasma triglycerides? Biochim. Biophys. Acta. 1821:843-851.
39. Lewis, G. F., K. D. Uffelman, L. W. Szeto, and G. Steiner. 1993. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 42:833-842. (Pubitemid 23151575)
40. Baker, P. W., and G. F. Gibbons. 2000. Effect of dietary fish oil on the sensitivity of hepatic lipid metabolism to regulation by insulin. J. Lipid Res. 41:719-726. (Pubitemid 30314127)
41. Muoio, D. M., P. S. MacLean, D. B. Lang, S. Li, J. A. Houmard, J. M. Way, D. A. Winegar, J. C. Corton, G. L. Dohm, and W. E. Kraus. 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277:26089-26097. (Pubitemid 34967092)
42. Kleiner, S., V. Nguyen-Tran, O. Baré, X. Huang, B. Spiegelman, and Z. Wu. 2009. PPAR{delta} agonism activates fatty acid oxidation via PGC-1{alpha} but does not increase mitochondrial gene expression and function. J. Biol. Chem. 284:18624-18633.
43. Drover, V. A., M. Ajmal, F. Nassir, N. O. Davidson, A. M. Nauli, D. Sahoo, P. Tso, and N. A. Abumrad. 2005. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J. Clin. Invest. 115:1290-1297. (Pubitemid 40629048)
44. Tran, T. T., H. Poirier, L. Clément, F. Nassir, M. M. Pelsers, V. Petit, P. Degrace, M. C. Monnot, J. F. Glatz, N. A. Abumrad, et al. 2011. Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis. J. Biol. Chem. 286:25201-25210.
45. Masuda, D., K. Hirano, H. Oku, J. C. Sandoval, R. Kawase, M. Yuasa-Kawase, Y. Yamashita, M. Takada, K. Tsubakio-Yamamoto, Y. Tochino, et al. 2009. Chylomicron remnants are increased in the postprandial state in CD36 deficiency. J. Lipid Res. 50:999-1011.
46. McFarlan, J. T., Y. Yoshida, S. S. Jain, X. X. Han, L. A. Snook, J. Lally, B. K. Smith, J. F. Glatz, J. J. Luiken, R. A. Sayer, et al. 2012. In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation. J. Biol. Chem. 287:23502-23516.
47. Rakhshandehroo, M., B. Knoch, M. Müller, and S. Kersten. 2010. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010:612089.